Interesting how the SP has played out in the past few...

Interesting how the SP has played out in the past few weeks.
Closing today smack bang on $1.85 61.8% Fibonnaci level as next level of resistance. If it breaks through then would be looking at $2.30 50% Fib level as next resistance.
Support at $1.30 76.4% Fib level proved strong and well done to those that topped up
Still plenty of buying opportunity in the next few months given overall market sentiment. Some key dates in July that might incur market volatility, release of June 2022 CPI data 13 July and Fed rate meeting 26&27 July

Today's Switzer July event with Ron and Scott provided some really good updates:

• Consumables, cap $20ea, liquid to support coupling of headset
• Substantial market opportunity with initial focus on 1st gen 10,200 Nth America, 1,600 hospital w/ comprehensive strokewards/units, 2nd gen 50,000 first responder point of call ambulance
• Shortly to occur, multi centre studies, major milestone
• Gen 1 priced at $100-150k (upper end of ultrasound which can be up to $250k)
• Gen 2 will be priced more efficiently for large fleet of ambulances
• Looking at 2 models CAPEX (purchasing model) and OPEX (manage equipment)

enjoy the RONjourney, block out the noise and see this through to commercialisation, distribution and beyond

77.6M shares, probably no need for cap raising anytime soon given grants and the AUS government will do everything to back this company and make it a good Aussie company success story for the world to see, target $1B MC = $12.88 SP
$1B+ MC not that far fetched given the quality of the EMV team and historic track record at previous successful companies